Neutron capture cross sections of tungsten and rhenium Annual summary report

Neutron capture cross sections for natural tungsten and rheniu

Tungsten nuclear rocket, phase I, part 1 Final report

Tungsten water moderated nuclear rocket reactor experiments and analyse

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

Passive immunization against β-amyloid (Aβ) has become an increasingly desirable strategy as a therapeutic treatment for Alzheimer's disease (AD). However, traditional passive immunization approaches carry the risk of Fcγ receptor-mediated overactivation of microglial cells, which may contribute to an inappropriate proinflammatory response leading to vasogenic edema and cerebral microhemorrhage. Here, we describe the generation of a humanized anti-Aβ monoclonal antibody of an IgG4 isotype, known as MABT5102A (MABT). An IgG4 subclass was selected to reduce the risk of Fcγ receptor-mediated overactivation of microglia. MABT bound with high affinity to multiple forms of Aβ, protected against Aβ1-42 oligomer-induced cytotoxicity, and increased uptake of neurotoxic Aβ oligomers by microglia. Furthermore, MABT-mediated amyloid plaque removal was demonstrated using in vivo live imaging in hAPP((V717I))/PS1 transgenic mice. When compared with a human IgG1 wild-type subclass, containing the same antigen-binding variable domains and with equal binding to Aβ, MABT showed reduced activation of stress-activated p38MAPK (p38 mitogen-activated protein kinase) in microglia and induced less release of the proinflammatory cytokine TNFα. We propose that a humanized IgG4 anti-Aβ antibody that takes advantage of a unique Aβ binding profile, while also possessing reduced effector function, may provide a safer therapeutic alternative for passive immunotherapy for AD. Data from a phase I clinical trial testing MABT is consistent with this hypothesis, showing no signs of vasogenic edema, even in ApoE4 carriers

10

The 10B(n,α) reaction cross-section is a well-established neutron cross-section standard for incident neutron energies up to 1 MeV. However, above this energy limit there are only scarce direct (n,α) measurements available and these few experimental data are showing large inconsistencies with each other. These discrepancies are reflected in the evaluated data libraries: ENDF/B-VII.1, JEFF-3.1.2 and JENDL-4.0 are in excellent agreement up to 100 keV incident neutrons, whereas the 10B(n,α) data in the different libraries show large differences in the MeV region. To address these inconsistencies, we have measured the cross section of the two branches of the 10B(n,α) reaction for incident neutron energies up to 3 MeV. We present here the 10B(n,α) and the 10B(n,α1γ) reactions cross section data, their branching ratio and the total 10B(n,α) reaction cross section. The measurements were conducted with a dedicated Frisch-grid ionization chamber installed at the GELINA pulsed neutron source of the EC-JRC. We compare our results with existing experimental data and evaluations

Hanford Works Report HW-61761

The relative neutron capture gamma production in several prospective iron thermal shielding materials for the New Production Reactor was measured to determine the merit of adding boron to the metal. It was found that for the beam geometry the used addition of 1 1/2 percent boron to the iron before casting reduced the soft gamma production by a factor of 6.5 and the hard gamma production by a factor of 10. No attempt was made to measure gamma or neutron transmissions